Funded Tech Companies
Inotek Pharmaceuticals
Inotek Pharmaceuticals is a leading biopharmaceutical tech venture, located in Walnut Creek. VC investment came from MedImmune Ventures, Rho Ventures and Pitango Venture Capital.
Company Overview
Company Name
Inotek Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1202 Water St.
Walnut Creek, CA 94597
USA
Walnut Creek, CA 94597
USA
Phone
Website
Email Address
Company Background Information
Overview
Inotek Pharmaceuticals is a clinical-stage, publicly traded, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/19/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Southwell
Chief Medical Officer
Rudolf Baumgartner
Chief Scientific Officer
William McVicar
VP - Finance
Dale Ritter
Company Investors
- MedImmune Ventures (Maggie LeFlore)
- Rho Ventures (Joshua Ruch)
- Pitango Venture Capital (Ittai Harel)
- Devon Park Bioventures (John Leamon)
- Care Capital (Jerry Karabelas)
- Horizon Technology Finance
- Edbi
- Devon Park Bioventures (John Leaman)
- Mitsubishi Corporation
- Pitango Venture Capital (Nissim Darvish)
- CDC - Caisse des Depots
- Hercules Technology Growth Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs